{"pmid":32325026,"title":"Endothelial cell infection and endotheliitis in COVID-19.","text":["Endothelial cell infection and endotheliitis in COVID-19.","Lancet","Varga, Zsuzsanna","Flammer, Andreas J","Steiger, Peter","Haberecker, Martina","Andermatt, Rea","Zinkernagel, Annelies S","Mehra, Mandeep R","Schuepbach, Reto A","Ruschitzka, Frank","Moch, Holger","32325026"],"journal":"Lancet","authors":["Varga, Zsuzsanna","Flammer, Andreas J","Steiger, Peter","Haberecker, Martina","Andermatt, Rea","Zinkernagel, Annelies S","Mehra, Mandeep R","Schuepbach, Reto A","Ruschitzka, Frank","Moch, Holger"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32325026","week":"202017|Apr 20 - Apr 26","doi":"10.1016/S0140-6736(20)30937-5","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664895932651536384,"score":8.518259,"similar":[{"pmid":32305740,"pmcid":"PMC7156948","title":"Severe COVID-19 infection associated with endothelial activation.","text":["Severe COVID-19 infection associated with endothelial activation.","Thromb Res","Escher, Robert","Breakey, Neal","Lammle, Bernhard","32305740"],"journal":"Thromb Res","authors":["Escher, Robert","Breakey, Neal","Lammle, Bernhard"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305740","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.thromres.2020.04.014","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664641855726288896,"score":159.70142},{"pmid":32314798,"title":"COVID-19 Infection in Patients with Sickle Cell Disease.","text":["COVID-19 Infection in Patients with Sickle Cell Disease.","Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, has spread to 184 countries with almost 1.5 million cases as of mid-April 2020 since first reported (1). The clinical features of this disease are not completely understood, however severe illness is thought to predominantly occur in adults with advanced age and those with underlying comorbidities (2). Sickle cell disease (SCD), an immunocompromised condition, puts patients at higher risk for respiratory infections and subsequent pulmonary complications such as acute chest syndrome (ACS) (3).","Br J Haematol","Hussain, Faiz A","Njoku, Franklin U","Saraf, Santosh L","Molokie, Robert E","Gordeuk, Victor R","Han, Jin","32314798"],"abstract":["Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, has spread to 184 countries with almost 1.5 million cases as of mid-April 2020 since first reported (1). The clinical features of this disease are not completely understood, however severe illness is thought to predominantly occur in adults with advanced age and those with underlying comorbidities (2). Sickle cell disease (SCD), an immunocompromised condition, puts patients at higher risk for respiratory infections and subsequent pulmonary complications such as acute chest syndrome (ACS) (3)."],"journal":"Br J Haematol","authors":["Hussain, Faiz A","Njoku, Franklin U","Saraf, Santosh L","Molokie, Robert E","Gordeuk, Victor R","Han, Jin"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314798","week":"202017|Apr 20 - Apr 26","doi":"10.1111/bjh.16734","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664714520074911746,"score":60.678596},{"pmid":32243621,"title":"COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.","text":["COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient.","Am J Hematol","Beerkens, Frans","John, Mira","Puliafito, Benjamin","Corbett, Virginia","Edwards, Colleen","Tremblay, Douglas","32243621"],"journal":"Am J Hematol","authors":["Beerkens, Frans","John, Mira","Puliafito, Benjamin","Corbett, Virginia","Edwards, Colleen","Tremblay, Douglas"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243621","week":"202014|Mar 30 - Apr 05","doi":"10.1002/ajh.25809","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664638249366192129,"score":49.96154},{"pmid":32282871,"title":"Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19).","text":["Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19).","Ann Intern Med","Zhang, Yulin","Gao, Yuxue","Qiao, Luxin","Wang, Wenjing","Chen, Dexi","32282871"],"journal":"Ann Intern Med","authors":["Zhang, Yulin","Gao, Yuxue","Qiao, Luxin","Wang, Wenjing","Chen, Dexi"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282871","week":"202016|Apr 13 - Apr 19","doi":"10.7326/L20-0227","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664636703952863232,"score":48.41942},{"pmid":32282956,"title":"Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.","text":["Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.","Am J Hematol","De Luna, Gonzalo","Habibi, Anoosha","Deux, Jean Francois","Colard, Martin","d'Alexandry d'Orengiani, Anne Laure Pham Hung","Schlemmer, Frederic","Joher, Nizar","Kassasseya, Christian","Pawlotsky, Jean Michel","Ourghanlian, Clement","Michel, Marc","Mekontso-Dessap, Armand","Bartolucci, Pablo","32282956"],"journal":"Am J Hematol","authors":["De Luna, Gonzalo","Habibi, Anoosha","Deux, Jean Francois","Colard, Martin","d'Alexandry d'Orengiani, Anne Laure Pham Hung","Schlemmer, Frederic","Joher, Nizar","Kassasseya, Christian","Pawlotsky, Jean Michel","Ourghanlian, Clement","Michel, Marc","Mekontso-Dessap, Armand","Bartolucci, Pablo"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282956","week":"202016|Apr 13 - Apr 19","doi":"10.1002/ajh.25833","source":"PubMed","topics":["Case Report"],"weight":1,"e_drugs":["tocilizumab"],"_version_":1664636703972786176,"score":47.111767}]}